Bigelow Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Buy |
2,065
+24
| +1% | +$13K | 0.41% | 62 |
|
|
2025
Q4 | $1.18M | Buy |
2,041
+39
| +2% | +$22.1K | 0.46% | 58 |
|
|
2025
Q3 | $971K | Sell |
2,002
-37
| -2% | -$17.2K | 0.39% | 69 |
|
|
2025
Q2 | $827K | Sell |
2,039
-24
| -1% | -$10K | 0.36% | 76 |
|
|
2025
Q1 | $1.03M | Buy |
2,063
+21
| +1% | +$11.4K | 0.49% | 60 |
|
|
2024
Q4 | $1.06M | Sell |
2,042
-240
| -11% | -$132K | 0.5% | 58 |
|
|
2024
Q3 | $1.41M | Buy |
2,282
+28
| +1% | +$16.6K | 0.63% | 50 |
|
|
2024
Q2 | $1.25M | Sell |
2,254
-23
| -1% | -$13.2K | 0.6% | 49 |
|
|
2024
Q1 | $1.32M | Buy |
2,277
+64
| +3% | +$35.9K | 0.65% | 43 |
|
|
2023
Q4 | $1.17M | Sell |
2,213
-30
| -1% | -$14.5K | 0.64% | 49 |
|
|
2023
Q3 | $1.14M | Buy |
2,243
+8
| +0.4% | +$4.26K | 0.65% | 48 |
|
|
2023
Q2 | $1.17M | Buy |
2,235
+68
| +3% | +$36.7K | 0.64% | 48 |
|
|
2023
Q1 | $1.25M | Sell |
2,167
-62
| -3% | -$34.9K | 0.72% | 42 |
|
|
2022
Q4 | $1.23M | Sell |
2,229
-73
| -3% | -$38.7K | 0.71% | 47 |
|
|
2022
Q3 | $1.17M | Buy |
2,302
+162
| +8% | +$90.7K | 0.7% | 44 |
|
|
2022
Q2 | $1.16M | Buy |
2,140
+147
| +7% | +$80.9K | 0.64% | 48 |
|
|
2022
Q1 | $1.18M | Buy |
1,993
+147
| +8% | +$84.4K | 0.55% | 52 |
|
|
2021
Q4 | $1.23M | Sell |
1,846
-18
| -1% | -$11.2K | 0.56% | 48 |
|
|
2021
Q3 | $1.06M | Sell |
1,864
-169
| -8% | -$92.8K | 0.52% | 53 |
|
|
2021
Q2 | $1.03M | Buy |
2,033
+10
| +0.5% | +$4.72K | 0.5% | 56 |
|
|
2021
Q1 | $923K | Buy |
2,023
+262
| +15% | +$125K | 0.47% | 59 |
|
|
2020
Q4 | $820K | Buy |
1,761
+147
| +9% | +$68.9K | 0.43% | 62 |
|
|
2020
Q3 | $713K | Buy |
1,614
+52
| +3% | +$21.5K | 0.42% | 61 |
|
|
2020
Q2 | $566K | Buy |
1,562
+467
| +43% | +$157K | 0.37% | 70 |
|
|
2020
Q1 | $311K | Sell |
1,095
-250
| -19% | -$78.8K | 0.23% | 111 |
|
|
2019
Q4 | $437K | Sell |
1,345
-50
| -4% | -$15.2K | 0.26% | 105 |
|
|
2019
Q3 | $406K | Sell |
1,395
-70
| -5% | -$20K | 0.26% | 105 |
|
|
2019
Q2 | $430K | Hold |
1,465
| – | – | 0.29% | 98 |
|
|
2019
Q1 | $401K | Sell |
1,465
-200
| -12% | -$49.8K | 0.28% | 100 |
|
|
2018
Q4 | $373K | Hold |
1,665
| – | – | 0.28% | 104 |
|
|
2018
Q3 | $406K | Sell |
1,665
-300
| -15% | -$69K | 0.27% | 107 |
|
|
2018
Q2 | $407K | Hold |
1,965
| – | – | 0.28% | 103 |
|
|
2018
Q1 | $406K | Buy |
+1,965
| New | +$412K | 0.28% | 104 |
|
Other funds holding TMO
VCM
Bigelow Investment Advisors's TMO Position: Q1 2026 in Review
Bigelow Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, buying an estimated $13K and bringing the position to 2,065 shares worth $1.02M. The position accounts for 0.41% of the portfolio, ranked #62.
Bigelow Investment Advisors first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.41M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Bigelow Investment Advisors held 2,065 shares of Thermo Fisher Scientific worth $1.02M as of Q1 2026.
- Bigelow Investment Advisors bought 24 Thermo Fisher Scientific shares in Q1 2026, an estimated $13K.
- Thermo Fisher Scientific made up 0.41% of Bigelow Investment Advisors's portfolio in Q1 2026, its #62 holding.
- Bigelow Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Bigelow Investment Advisors's Thermo Fisher Scientific position peaked at $1.41M in Q3 2024.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Bigelow Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.